RHO Ventures VI LP is 10% Owner at Cara Therapeutics, Inc. (CARA). They have made 1 open-market trade across 1 company since 2016, most recently 2016-03-17.
CIK 0001419636
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $1.9M since 2016, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CARA | 2,820,330 | $15.0M |
Shares reported on the most recent Form 4, priced at the 2016-03-18 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CARA | BUY | 2016-03-16 | 2016-03-18 | $4.87 | $1.9M | +16.3% | +51.8% | -1.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.